BackAdamas Pharmaceuticals Overview

Adamas Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for ADMS.

Quarterly SG&A Expenses

$29.73M
↑ 13.82% YoY

As of Sep 30, 2021

Annual SG&A Expenses (TTM)

$118.51M
↑ 13.81% YoY

Trailing 12 months ending Sep 30, 2021

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin